(Q44888480)

7 December 2017

title

Epigenetic regulation of melanoma tumor suppressor miRNA-124a (English)

1 reference

7 December 2017

Ali R Jazirehi

1

1 reference

7 December 2017

Antoni X Torres-Collado

series ordinal

2

1 reference

7 December 2017

Ramin Nazarian

series ordinal

3

1 reference

7 December 2017

publication date

1 June 2013

1 reference

7 December 2017

1 reference

7 December 2017

volume

5

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

251-252

1 reference

Ocular melanoma: a review and the relationship to cutaneous melanoma

7 December 2017

cites work

1 reference

Uveal melanoma: trends in incidence, treatment, and survival

21 January 2018

1 reference

MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.

21 January 2018

1 reference

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

21 January 2018

1 reference

Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides

21 January 2018

1 reference

The role of EZH2 in tumour progression

21 January 2018

1 reference

Functions of DNA methylation: islands, start sites, gene bodies and beyond

21 January 2018

1 reference

A decade of exploring the cancer epigenome - biological and translational implications

21 January 2018

1 reference

Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development

21 January 2018

1 reference

Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.

21 January 2018

1 reference

Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies

21 January 2018

1 reference

Serum microRNAs as biomarkers for recurrence in melanoma.

21 January 2018

1 reference

Diagnostic value of melanoma inhibitory activity serum marker in the follow-up of patients with stage I or II cutaneous melanoma.

21 January 2018

1 reference

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study.

21 January 2018

1 reference

Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.

21 January 2018

1 reference

Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line

21 January 2018

1 reference

Knockdown of TFPI-2 promotes migration and invasion of glioma cells

21 January 2018

1 reference

CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion

21 January 2018

1 reference

Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas.

21 January 2018

1 reference

Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells.

21 January 2018

1 reference

Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

DNA methylation of cancer genome.

21 January 2018

1 reference

Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance

21 January 2018

1 reference

DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer

21 January 2018

1 reference

Characterization of DNA demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndrome.

21 January 2018

1 reference

Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion

21 January 2018

1 reference

Role of human nucleoside transporters in the uptake and cytotoxicity of azacitidine and decitabine

21 January 2018

1 reference

Design and engineering of nanogels for cancer treatment

21 January 2018

1 reference

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

Clinical applications for microRNAs in cancer

21 January 2018

1 reference

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

21 January 2018

1 reference

A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network

21 January 2018

1 reference

The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.13.23

1 reference

7 December 2017

1 reference